Mimedx Group Inc (MDXG)

$4.10 -0.03 (-0.73%)
Market Cap 629.92M
Revenue (ttm) 418.63M
Net Income (ttm) 48.58M
EPS (ttm) N/A
PE Ratio 9.16
Forward PE 37.46
Profit Margin 11.60%
Debt to Equity Ratio 0.01
Volume 578,800
Avg Vol 1,041,672
Day's Range N/A - N/A
Shares Out 148.57M
Stochastic %K 11%
Beta 1.60
Analysts Strong Sell
Price Target $9.67

Company Profile

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techni...

Industry: Biotechnology
Sector: Healthcare
Phone: 770 651 9100
Address:
1775 West Oak Commons Court, NE, Marietta, United States
biomaster22
biomaster22 Mar. 25 at 11:23 PM
$MDXG where is the millions of dollar buy back crapper you lying fck
0 · Reply
Monticello4
Monticello4 Mar. 25 at 8:40 PM
$MDXG “Definitely hitting $500 by tomorrow...” Who pays you to be so consistently stupid?
0 · Reply
Monticello4
Monticello4 Mar. 25 at 8:28 PM
$MDXG .
0 · Reply
Mobagri
Mobagri Mar. 25 at 8:08 PM
$MDXG On a Green Day for most stocks MDXG breaks another low record!
1 · Reply
Monticello4
Monticello4 Mar. 24 at 8:46 PM
$MDXG Short Interest just released: MiMedx short interest dropped 529,826 shares…significant Orgogenesis short interest dropped 22,712…insignificant
0 · Reply
Monticello4
Monticello4 Mar. 23 at 8:35 PM
$MDXG .
0 · Reply
Monticello4
Monticello4 Mar. 23 at 8:16 PM
$MDXG Just simple facts...the 3 TITs hate facts...
0 · Reply
Daddys_Home
Daddys_Home Mar. 23 at 7:42 PM
$MDXG 😂📉
0 · Reply
Monticello4
Monticello4 Mar. 23 at 2:44 PM
$MDXG .
1 · Reply
Mobagri
Mobagri Mar. 23 at 2:35 PM
$MDXG Monticello AKA Gummy calls himself “professional” 😂😂😂😂. Your cartoons speak for itself. Immature, childish old man who is so defensive against anyone expressing their negative opinion about one stock. He holds his employment for MDXG a secret like he’s embarrassed
0 · Reply
Latest News on MDXG
MIMEDX Announces Launch of CHORIOFIX™

Mar 23, 2026, 8:00 AM EDT - 2 days ago

MIMEDX Announces Launch of CHORIOFIX™

MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields

Mar 5, 2026, 8:00 AM EST - 20 days ago

MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields

MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call Transcript

Feb 25, 2026, 7:07 PM EST - 27 days ago

MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call Transcript

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

Feb 25, 2026, 4:01 PM EST - 4 weeks ago

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

Feb 17, 2026, 8:00 AM EST - 5 weeks ago

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

Feb 4, 2026, 10:27 AM EST - 7 weeks ago

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®

Feb 2, 2026, 8:00 AM EST - 7 weeks ago

MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel

Dec 22, 2025, 9:43 AM EST - 3 months ago

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial

Nov 13, 2025, 8:00 AM EST - 4 months ago

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial

MIMEDX to Participate in Upcoming Investor Conferences

Nov 10, 2025, 4:01 PM EST - 4 months ago

MIMEDX to Participate in Upcoming Investor Conferences

MiMedx: Breakout Setup Into A Policy Overhaul

Nov 4, 2025, 9:56 AM EST - 5 months ago

MiMedx: Breakout Setup Into A Policy Overhaul

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule

Nov 3, 2025, 9:15 AM EST - 5 months ago

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule

MiMedx Group, Inc. (MDXG) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 6:56 PM EDT - 5 months ago

MiMedx Group, Inc. (MDXG) Q3 2025 Earnings Call Transcript

MIMEDX Announces Record Revenue for Third Quarter 2025

Oct 29, 2025, 4:01 PM EDT - 5 months ago

MIMEDX Announces Record Revenue for Third Quarter 2025

MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29

Oct 15, 2025, 8:00 AM EDT - 5 months ago

MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29

MIMEDX Announces Launch of EPIXPRESS®

Oct 6, 2025, 9:28 AM EDT - 6 months ago

MIMEDX Announces Launch of EPIXPRESS®

MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall

Sep 3, 2025, 8:00 AM EDT - 7 months ago

MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall

MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 11:01 PM EDT - 8 months ago

MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript

MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results

Jul 30, 2025, 4:01 PM EDT - 8 months ago

MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results

MIMEDX Announces Strategic Collaboration with Vaporox, Inc.

Jul 30, 2025, 8:00 AM EDT - 8 months ago

MIMEDX Announces Strategic Collaboration with Vaporox, Inc.

MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30

Jul 16, 2025, 8:00 AM EDT - 9 months ago

MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

Jul 15, 2025, 9:15 AM EDT - 9 months ago

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

May 6, 2025, 8:00 AM EDT - 11 months ago

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

May 5, 2025, 8:30 AM EDT - 11 months ago

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 9:52 PM EDT - 11 months ago

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

MIMEDX Announces First Quarter 2025 Operating and Financial Results

Apr 30, 2025, 4:01 PM EDT - 11 months ago

MIMEDX Announces First Quarter 2025 Operating and Financial Results

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

Apr 10, 2025, 4:01 PM EDT - 1 year ago

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

Feb 27, 2025, 8:00 AM EST - 1 year ago

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 10:50 PM EST - 1 year ago

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

Feb 26, 2025, 4:01 PM EST - 1 year ago

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

Nov 14, 2024, 9:15 AM EST - 1 year ago

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 9:38 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

Oct 30, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

Oct 14, 2024, 8:00 AM EDT - 1 year ago

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

Oct 8, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

Oct 1, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

Sep 11, 2024, 1:03 PM EDT - 1 year ago

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

Sep 4, 2024, 4:23 PM EDT - 1 year ago

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

Aug 26, 2024, 9:30 AM EDT - 1 year ago

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 9:10 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

Jul 31, 2024, 4:02 PM EDT - 1 year ago

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

Jul 31, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

Jul 22, 2024, 8:10 AM EDT - 1 year ago

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

Jun 26, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 9:33 PM EDT - 2 years ago

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

MIMEDX Announces First Quarter 2024 Operating and Financial Results

Apr 30, 2024, 4:01 PM EDT - 2 years ago

MIMEDX Announces First Quarter 2024 Operating and Financial Results

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

Apr 16, 2024, 8:00 AM EDT - 2 years ago

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

Mar 20, 2024, 7:00 AM EDT - 2 years ago

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 8:46 PM EST - 2 years ago

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

Feb 28, 2024, 4:01 PM EST - 2 years ago

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

biomaster22
biomaster22 Mar. 25 at 11:23 PM
$MDXG where is the millions of dollar buy back crapper you lying fck
0 · Reply
Monticello4
Monticello4 Mar. 25 at 8:40 PM
$MDXG “Definitely hitting $500 by tomorrow...” Who pays you to be so consistently stupid?
0 · Reply
Monticello4
Monticello4 Mar. 25 at 8:28 PM
$MDXG .
0 · Reply
Mobagri
Mobagri Mar. 25 at 8:08 PM
$MDXG On a Green Day for most stocks MDXG breaks another low record!
1 · Reply
Monticello4
Monticello4 Mar. 24 at 8:46 PM
$MDXG Short Interest just released: MiMedx short interest dropped 529,826 shares…significant Orgogenesis short interest dropped 22,712…insignificant
0 · Reply
Monticello4
Monticello4 Mar. 23 at 8:35 PM
$MDXG .
0 · Reply
Monticello4
Monticello4 Mar. 23 at 8:16 PM
$MDXG Just simple facts...the 3 TITs hate facts...
0 · Reply
Daddys_Home
Daddys_Home Mar. 23 at 7:42 PM
$MDXG 😂📉
0 · Reply
Monticello4
Monticello4 Mar. 23 at 2:44 PM
$MDXG .
1 · Reply
Mobagri
Mobagri Mar. 23 at 2:35 PM
$MDXG Monticello AKA Gummy calls himself “professional” 😂😂😂😂. Your cartoons speak for itself. Immature, childish old man who is so defensive against anyone expressing their negative opinion about one stock. He holds his employment for MDXG a secret like he’s embarrassed
0 · Reply
Mobagri
Mobagri Mar. 23 at 2:13 PM
$MDXG this guy is Gunny’s squeeze
0 · Reply
Mobagri
Mobagri Mar. 23 at 2:12 PM
$MDXG temporary price hike due to oil dropping. Take advantage of today and rid this junk before it drops below $4 Last warning
0 · Reply
Mobagri
Mobagri Mar. 23 at 2:09 PM
$MDXG hahahaha. What a stupid prediction.
0 · Reply
Mobagri
Mobagri Mar. 23 at 1:54 PM
$MDXG what a joke.
0 · Reply
njbugatti
njbugatti Mar. 23 at 1:07 PM
$MDXG https://mimedx.gcs-web.com/news-releases/news-release-details/mimedx-announces-launch-choriofixtm something is better than nothing!
0 · Reply
Monticello4
Monticello4 Mar. 21 at 9:32 AM
$MDXG .
1 · Reply
Daddys_Home
Daddys_Home Mar. 20 at 11:17 PM
$MDXG who dumped 4m shares at the close? Monday will be interesting📉⏳💣🔥
2 · Reply
Monticello4
Monticello4 Mar. 20 at 11:07 PM
$MDXG .
1 · Reply
Monticello4
Monticello4 Mar. 20 at 8:37 PM
$MDXG why was Mobags-of-bullshit pumping orgo just before he sold it all....
0 · Reply
Mobagri
Mobagri Mar. 20 at 7:30 PM
$MDXG future earnings do not support market cap of 600M. Company is burning the 100M cash quickly, essentially running out of reserve by December. That’s when the market value of the company should hover around 300M. That will bring the stock price to below $3 per share by 2027.
0 · Reply
Monticello4
Monticello4 Mar. 20 at 2:16 PM
$MDXG HEY BOZO...
0 · Reply
Monticello4
Monticello4 Mar. 20 at 2:11 PM
$MDXG 🤣
0 · Reply